Huperzine A
A potent acetylcholinesterase inhibitor sold as a supplement, which is a category error: it is pharmacologically a drug. Alzheimer's trials look positive but are almost entirely small, low-quality and from a single country, and there is essentially no evidence it helps healthy people.
What the science says
- Alzheimer's disease Limited evidence
A 2013 systematic review and meta-analysis of randomized trials found huperzine A improved MMSE and activities-of-daily-living scores versus placebo in Alzheimer's disease. The authors explicitly rated the methodological quality of the included trials as poor, with almost all conducted in China and inadequate reporting of randomization and blinding, so the pooled effect is unreliable.
- Mild cognitive impairment Limited evidence
A Cochrane review of huperzine A for mild cognitive impairment identified only one eligible trial and concluded there was insufficient evidence to determine any effect. No adequately powered MCI trial has been published since.
- Cognitive enhancement in healthy adults Limited evidence
There are no good placebo-controlled trials of huperzine A in cognitively normal adults, and it appears in nootropic stacks largely on mechanistic reasoning. Inhibiting acetylcholinesterase in a healthy brain is not obviously beneficial and carries real cholinergic side effects.
Dosage & safety
Scientific references
Where to buy
California Gold Nutrition, Huperzine A, 250 mcg , 90 Veggie Capsules
View on iHerbReferral link — this site may earn a commission on purchases.
Related in Brain & cognition
- Vitamin B2 (Riboflavin) Moderate evidence
- Choline Moderate evidence
- Magnesium L-Threonate Limited evidence
- Phosphatidylserine Limited evidence
- Lecithin (Phosphatidylcholine) Limited evidence
- Agmatine Sulfate Limited evidence